A major driving factor of the market is a surge in generic drug manufacturers. The lower cost of antidepressants and other drugs has encouraged people to opt for the treatment. Moreover, a rise in awareness about the treatment is also encouraging people to opt for the procedure. Rising awareness has led people to gather more knowledge about the disease and get rid of the old stigma attached to it. People are understanding the need for treatment and opting for it for a healthier lifestyle.
In October 2020, a global biotech company, ATAI Life Sciences, has launched Viridia Life Sciences for the development of formulations of N, N-dimethyltryptamine (DMT) to investigate the efficiency of digital therapeutics with resistant depression.
Read More@: https://www.emergenresearch.com/industry-report/depression-treatment-market
Key Highlights From The Report
Hospitals held the largest share in the year 2019 as most of the depressed cases were recognized when registered at a hospital for treatment. Not many are aware of their symptoms and visit hospitals to get treated when the situation become a little extreme. There are also special wards and doctors for patients who are going through depression during their treatment.
Key participants include Pfizer, Inc., AstraZeneca, Plc, GlaxoSmithKline Plc, Eily, Lilly, and Company, Allergan Plc, Takeda Pharmaceutical Company Limited, Intellipharmaceutics International, Inc., Otsuka Holdings Co. Ltd., H.Lundbeck A/S, and Apotex, Inc., among others.
Antipsychotics treatment has been used to treat depressive disorders. The medicine was used in combination with antidepressants and became the choice of treatment for depressed patients who had psychotic symptoms. The antipsychotic treatment was done to treat symptoms such as delusions, hallucinations, or marina symptoms. It is also used to treat bipolar depression.
Major Depressive Disorder (MDD), also known as clinical depression, is a condition that impacts behavior and mood as well as physical functions, like appetite and sleep. It is among the most common mental health condition, and studies suggest that almost 7% of the adults in the United States suffered from the disease in 2017.
For the purpose of this report, Emergen Research has segmented into the global Depression Treatment Market on the basis of drug type, application, end-user, distribution channel, and region:
Drug Type Outlook (Revenue, USD Billion; 2017-2027)
Antidepressants
Selective Serotonin Reuptake Inhibitors (SSRIs)
Selective Norepinephrine Reuptake Inhibitors (SNRIs)
Serotonin Modulators
Tricyclic Tetracyclic Antidepressants
Atypical Antidepressants
Antipsychotics
Others
Application Outlook (Revenue, USD Billion; 2017-2027)
Major Depressive Disorder (MDD)
Bipolar Disorder
Postpartum Depression
Premenstrual Dysphoric Disorder (PMDD)
Dysthymic Disorder
Seasonal Affective Disorder (SAD)
Others
End-User Outlook (Revenue, USD Billion; 2017-2027)
Hospitals
NGOs
Mental Health Centers
Asylums
Others
Distribution Channel Outlook (Revenue, USD Billion; 2017-2027)
Hospitals Pharmacies
Retail Pharmacies
Online
Regional Outlook: (Revenue, USD Billion; 2018-2028)
North America (U.S.) (Canada) (Mexico)
Europe (Germany) (UK) (France) (BENELUX) (Rest of Europe)
Asia Pacific (China) (Japan) (South Korea) (Rest of APAC)
Latin America (Brazil) (Rest of LATAM)
Get a Free Sample Report@: https://www.emergenresearch.com/request-sample/191
Table of Content
Chapter 1. Methodology Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Depression Treatment Market Segmentation Impact Analysis
4.1. Depression Treatment Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increase in geriatric population
4.2.2.2. Increase in issues with mental health
4.2.2.3. Minimal side effects
4.2.3. Market restraints analysis
4.2.3.1. The high cost of devices and therapies
4.2.3.2. Delay in diagnosis
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Continue…
Related Reports.
Wi-Fi 6 Devices Market Size Worth USD 27.42 Billion in 2028
Gaming Console Market Size Worth USD 54.21 Billion in 2028
Smart Greenhouse Market Size Worth USD 3.16 Billion in 2028
Horticulture Lighting Market Size Worth USD 11.27 Billion in 2028
Smart Dust Market Size Worth USD 900.1 Million in 2028
Radiofrequency-Based Devices Market Size Worth USD 9,595.9 Million in 2028
